Basil

Dosage for Basil allergenic extract is highly individualized and must be determined by an allergy specialist through a process of titration (adjusting the dose based on the patient's reaction).

Diagnostic Dosing

For skin prick testing (SPT), a single drop of the 1:10 or 1:20 w/v extract is applied to the skin, followed by a puncture with a sterile lancet. For intradermal testing, 0.02 mL to 0.05 mL of a highly diluted extract (e.g., 1:1,000 or 1:10,000) may be injected into the skin if the prick test is negative but clinical suspicion remains high.

Immunotherapy Dosing

If used for desensitization, the treatment is divided into two phases:

1. 1Build-up Phase: Starting with a very low dose (e.g., 0.05 mL of a 1:100,000 dilution), the volume and concentration are increased weekly or bi-weekly until the maintenance dose is reached.
2. 2Maintenance Phase: Once the patient reaches a therapeutic level (the "maintenance dose"), injections are typically given every 2 to 4 weeks. The maintenance dose is usually the highest dose the patient can tolerate without a significant systemic reaction.

Basil allergenic extracts are generally considered safe for use in children, provided the child is old enough to cooperate with the testing procedure (usually 2 years and older). Dosing for children is similar to adult dosing but requires extreme caution. The clinician may start at even higher dilutions to minimize the risk of a systemic reaction. There is no specific age-based weight adjustment, as the dose is determined by the patient's individual immunological sensitivity rather than body mass.

Renal Impairment

No dosage adjustment is typically required for patients with renal impairment, as the clearance of allergenic proteins does not rely on the kidneys. However, the patient's overall health must be stable before administration.

Hepatic Impairment

No dosage adjustment is required for hepatic impairment. The liver is not involved in the primary processing of these allergenic proteins.

Elderly Patients

Elderly patients may have reduced skin reactivity, which can lead to false-negative results during diagnostic testing. In immunotherapy, the risk of cardiovascular complications from a systemic reaction (anaphylaxis) is higher in the elderly, requiring more conservative dosing and closer monitoring.

Basil allergenic extract is NEVER for self-administration. It must be administered by a trained healthcare professional in a medical facility.

• Preparation: The clinician will clean the skin (usually the forearm or back) with alcohol before testing.
• Observation: After a skin test or an immunotherapy injection, the patient MUST remain in the doctor's office for at least 30 minutes. This is the period when life-threatening allergic reactions (anaphylaxis) are most likely to occur.
• Storage: Vials should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Freezing can denature the proteins, making the extract ineffective or dangerously unpredictable.

In immunotherapy, consistency is critical. If a maintenance dose is missed:

• 1 week late: The usual dose is generally given.
• 2-4 weeks late: The dose may need to be reduced by 25% to 50% to ensure safety.
• Over 4 weeks late: The build-up process may need to be restarted from a much lower concentration.

An "overdose" in the context of allergenic extracts refers to the administration of a concentration higher than the patient's current tolerance level. Signs of an overdose include:

• Rapid onset of hives (urticaria)
• Swelling of the throat or tongue (angioedema)
• Difficulty breathing or wheezing
• Rapid drop in blood pressure (hypotension)

Emergency Action: If an overdose occurs during administration, the clinician will immediately administer epinephrine (adrenaline) and may provide supplemental oxygen, IV fluids, and antihistamines.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not attempt to use these extracts outside of a clinical environment.

Most patients undergoing testing or treatment with Basil allergenic extract will experience localized reactions. These are generally not dangerous but can be uncomfortable.

• Localized Wheal and Flare: This is the expected result of a positive skin test. It feels like a mosquito bite—a raised, itchy, red bump. It typically appears within 15 minutes and resolves within 1 to 2 hours.
• Injection Site Redness and Swelling: In immunotherapy, the area where the shot was given may become red, warm, and swollen. This can last for 24 to 48 hours.
• Pruritus (Itching): Intense itching at the site of administration is very common.

• Large Local Reactions (LLR): Swelling that exceeds 5-10 cm in diameter at the injection site. This may be treated with cold compresses and over-the-counter pain relievers.
• Fatigue: Some patients report feeling unusually tired for several hours following an immunotherapy injection.
• Headache: A mild, transient headache may occur shortly after administration.

• Generalized Urticaria: Hives appearing on parts of the body far from the injection site.
• Rhinitis: Sneezing, runny nose, or nasal congestion triggered by the systemic absorption of the allergen.
• Mild Wheezing: A slight tightening of the chest or shortness of breath.

> Warning: Stop the procedure and call for emergency help immediately if you experience any of the following symptoms of anaphylaxis.

• Anaphylaxis: This is a life-threatening, multi-system allergic reaction. It can include a rapid pulse, a sudden drop in blood pressure, fainting, and severe airway constriction.
• Angioedema: Severe swelling of the lips, tongue, or throat that can obstruct the airway.
• Laryngeal Edema: Swelling of the larynx (voice box), which may manifest as a hoarse voice or a feeling of a "lump in the throat."
• Hypotension: A dangerous drop in blood pressure that can lead to shock.
• Cardiac Arrest: In extremely rare cases, severe anaphylaxis can lead to heart failure.

With prolonged immunotherapy, the primary long-term effect is the desired development of immunological tolerance. However, some patients may develop chronic "delayed" local reactions, where the injection site becomes hard or painful 6 to 12 hours after the shot. There is no evidence that long-term use of Basil extracts causes organ damage, cancer, or autoimmune diseases.

Allergenic extracts, including Basil, carry a significant risk of severe systemic reactions. While not always labeled with a traditional "Black Box" in the same way as oral medications, the FDA-approved package inserts for these biologics contain prominent warnings regarding Anaphylaxis Risk.

• Risk of Systemic Reactions: Basil allergenic extract can cause severe, life-threatening systemic reactions, including anaphylaxis.
• Setting: Administration must only occur in facilities equipped with personnel trained in the management of anaphylaxis and with immediate access to emergency medications like epinephrine.
• Patient Stability: Injections should not be given to patients with unstable asthma or those who have had a recent myocardial infarction (heart attack).

Report any unusual symptoms, especially those occurring hours after leaving the clinic, to your healthcare provider immediately.

Basil allergenic extract is a potent biological substance. It is only intended for use by specialists in allergy and immunology. Patients must be aware that every administration carries a small but real risk of a systemic allergic reaction. Before receiving Basil extract, you must inform your doctor if you are feeling unwell, have an active infection, or if your asthma symptoms have worsened in the last 48 hours.

No formal FDA black box warning is currently assigned specifically to Basil extract; however, the general class warning for all allergenic extracts applies: WARNING: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients should be observed for at least 30 minutes following administration.

• Anaphylaxis Risk: This is the primary concern. Patients with a history of severe reactions to very small amounts of allergens are at higher risk.
• Asthma Status: Patients with severe or poorly controlled asthma are at a significantly higher risk for a fatal reaction if they experience anaphylaxis. The FEV1 (Forced Expiratory Volume) should be monitored in asthmatic patients before each injection.
• Beta-Blocker Use: Patients taking beta-blockers (medications for blood pressure or heart conditions) may be resistant to the effects of epinephrine, the primary treatment for anaphylaxis. This makes any allergic reaction much harder to treat.
• Cardiovascular Disease: Patients with underlying heart disease may not tolerate the physiological stress of a systemic reaction or the epinephrine used to treat it.

• Post-Injection Observation: A mandatory 30-minute wait in the clinic after every dose.
• Peak Flow/Spirometry: For asthmatic patients, lung function may be checked before administration.
• Skin Reactivity: Periodic re-evaluation of skin test sensitivity to ensure the extract is still appropriate for the patient's current immune state.

Most patients can drive after the 30-minute observation period. However, if you experience dizziness, fatigue, or a mild systemic reaction, you should not drive or operate heavy machinery until the symptoms have completely resolved.

Alcohol should be avoided on the day of an immunotherapy injection. Alcohol can increase blood flow to the skin and potentially accelerate the absorption of the allergen, increasing the risk of a systemic reaction. It can also mask the early symptoms of anaphylaxis.

If a patient experiences a severe systemic reaction, the healthcare provider will re-evaluate the necessity of the treatment. Immunotherapy may be discontinued if the risks outweigh the benefits. There is no "withdrawal syndrome" associated with stopping Basil extracts, but the patient's allergy symptoms will likely return to their baseline levels over time.

> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Basil allergenic extract.

There are no drugs that are strictly contraindicated in the sense of a chemical incompatibility, but certain drugs make the use of Basil extract unacceptably dangerous:

• Non-Selective Beta-Blockers (e.g., Propranolol): These drugs block the receptors that epinephrine needs to work. If a patient on a beta-blocker has anaphylaxis from a Basil shot, the standard emergency treatment may fail, leading to death. Most allergists will not perform immunotherapy on patients taking these medications.

• Selective Beta-Blockers (e.g., Atenolol, Metoprolol): While slightly safer than non-selective versions, they still pose a significant risk during an allergic emergency.
• ACE Inhibitors (e.g., Lisinopril): These medications may increase the severity of anaphylactic reactions and are associated with a higher risk of angioedema. Use with caution during the build-up phase of immunotherapy.
• MAOIs (Monoamine Oxidase Inhibitors): These can interfere with the body's ability to process the medications used to treat anaphylaxis, potentially leading to a hypertensive crisis if epinephrine is administered.

• Tricyclic Antidepressants (TCAs): Similar to MAOIs, TCAs can potentiate the effects of epinephrine, requiring careful monitoring during emergency treatment.
• Systemic Corticosteroids: While they don't prevent the immediate "wheal and flare" of a skin test, long-term high-dose use can dampen the immune response, potentially making immunotherapy less effective.

• Cross-Reactive Foods: Patients allergic to Basil may also react to other members of the Lamiaceae family, such as oregano, thyme, mint, and rosemary. Consuming these foods shortly before or after a Basil injection may increase the total "allergen load" on the immune system, potentially triggering a reaction.
• High-Fat Meals: No direct interaction, but heavy meals can cause gastrointestinal discomfort that might be confused with the early signs of a systemic allergic reaction.

• Antihistamine-like Herbs: Supplements like stinging nettle or butterbur may have mild antihistamine effects, which could lead to a false-negative result on a Basil skin test.
• Feverfew: May interfere with platelet function and the inflammatory response, though the clinical significance for allergenic extracts is minimal.

• Skin Prick Tests: Basil extract is the subject of the test itself. However, taking antihistamines (e.g., Loratadine, Cetirizine, Diphenhydramine) within 3-7 days of the test will suppress the skin's reaction, leading to a false-negative result.
• Serum IgE Tests: The use of Basil extract in immunotherapy will eventually change the levels of Basil-specific IgE and IgG4 in the blood, which is an intended therapeutic effect rather than an "interaction."

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or depression.

Conditions where Basil allergenic extract must NEVER be used include:

1. 1Severe, Uncontrolled Asthma: Patients with a FEV1 consistently below 70% of predicted value are at an unacceptably high risk of fatal bronchospasm during a systemic reaction.
2. 2Recent Myocardial Infarction (Heart Attack): The heart must be stable to handle the potential stress of anaphylaxis or the administration of epinephrine.
3. 3History of Severe Anaphylaxis to Basil: If a patient has already had a near-fatal reaction to a minute amount of Basil, the risks of further testing or immunotherapy usually outweigh any potential benefits.
4. 4Beta-Blocker Therapy: As previously mentioned, the inability to respond to epinephrine makes the procedure too dangerous.

Conditions requiring a careful risk-benefit analysis by the physician:

• Autoimmune Diseases: There is a theoretical concern that stimulating the immune system with allergenic extracts could worsen conditions like Lupus or Rheumatoid Arthritis.
• Malignancy: Patients with active cancer may have compromised immune systems that do not respond predictably to immunotherapy.
• Severe Atopic Dermatitis: If the skin is too inflamed, it may be impossible to accurately read the results of a skin prick test.

Patients who are allergic to Basil often show cross-sensitivity to other plants in the Lamiaceae family. This includes:

• Oregano
• Thyme
• Lavender
• Peppermint
• Sage

If you have had a severe reaction to any of these herbs, you must inform your allergist before undergoing Basil testing, as you may be highly sensitive to the Basil extract as well.

> Important: Your healthcare provider will evaluate your complete medical history, including your lung and heart health, before prescribing or administering Basil extract.

FDA Pregnancy Category C: There are no adequate and well-controlled studies of Basil allergenic extract in pregnant women.

• Diagnostic Testing: It is generally recommended to postpone skin testing until after delivery to avoid the risk of anaphylaxis, which can cause fetal hypoxia (lack of oxygen to the baby).
• Immunotherapy: If a woman is already on a stable maintenance dose and becomes pregnant, the treatment is usually continued. However, the dose is never increased during pregnancy because the risk of a systemic reaction is highest during the build-up phase. Starting new immunotherapy during pregnancy is generally avoided.

It is not known whether the components of Basil extract or the antibodies produced during immunotherapy pass into breast milk. However, since these are proteins and naturally occurring antibodies, the risk to the nursing infant is considered very low. The primary concern remains the mother's safety and the potential for a reaction that could interfere with her ability to care for the infant.

Basil extracts are used in children for diagnosis and treatment. However, the benefits must be weighed against the distress of the procedure and the risk of systemic reactions. Children with significant asthma are at the same increased risk as adults. Most clinicians wait until a child is at least 5 years old before starting immunotherapy to ensure the child can communicate early symptoms of a reaction.

Patients over 65 years of age require special consideration. They are more likely to have co-morbidities such as coronary artery disease or COPD, which increase the danger of anaphylaxis. Additionally, the skin of older adults may be less reactive (atrophic), which can lead to smaller wheal sizes during testing and potentially misdiagnosis.

Renal impairment does not significantly alter the processing of allergenic extracts. However, patients with end-stage renal disease (ESRD) may have altered immune function, which could theoretically affect the efficacy of immunotherapy. No specific dose adjustments are published for this population.

There is no evidence that hepatic impairment affects the safety or efficacy of Basil extracts. The liver is not the primary site of action or metabolism for these biological products.

> Important: Special populations require individualized medical assessment and a cautious approach to any form of allergen exposure.

Basil allergenic extract works through the modulation of the Type I hypersensitivity pathway. In diagnosis, the extract provides the specific protein antigens (such as the putative allergen Oci b 1) that bind to IgE on the surface of mast cells. This cross-linking of IgE receptors triggers the release of pre-formed mediators like histamine.

In immunotherapy, the mechanism involves the induction of immune tolerance. This is achieved by increasing the population of Regulatory T cells (Tregs) and shifting the cytokine profile from Th2 (IL-4, IL-5) to Th1 (IFN-gamma). A critical component is the induction of IgG4, which acts as a competitive inhibitor, preventing the Basil allergens from reaching the IgE on mast cells.

• Onset of Action (Diagnostic): 15 to 20 minutes for a skin wheal to develop.
• Onset of Action (Therapeutic): 6 to 12 months of immunotherapy are usually required before a significant reduction in clinical symptoms is observed.
• Duration of Effect: Diagnostic results are transient. Therapeutic effects from a completed 3-to-5-year course of immunotherapy can last for several years or even decades.

| Parameter | Value |

|---|---|

| Bioavailability | N/A (Local/Subcutaneous) |

| Protein Binding | Primarily to IgE and IgG4 antibodies |

| Half-life | Proteins are degraded within hours; immunological memory lasts years |

| Tmax | 15-20 minutes (Skin reaction) |

| Metabolism | Proteolysis by antigen-presenting cells |

| Excretion | Minimal (Lymphatic clearance) |

• Composition: A complex mixture of proteins, glycoproteins, and polysaccharides extracted from Ocimum basilicum.
• Molecular Weight: Varies; primary allergenic proteins typically range from 10 to 70 kDa.
• Solubility: Highly soluble in aqueous and glycerinated buffers.
• Standardization: Non-standardized extracts are labeled in weight/volume (w/v) or Protein Nitrogen Units (PNU).

Basil extract is a Standardized/Non-Standardized Allergenic Extract. It is part of a broad class of biologicals that includes pollen, dust mite, and venom extracts used in clinical immunology.